[1]马少华,李同林,马勇△,等.基于Consort声明和改良Jadad量表评价中药治疗原发性骨质疏松症[J].中国中医骨伤科杂志,2015,23(01):22-25.
　Ma Shao-hua,Li Tong-lin,Ma Yong,et al.Accessing on Chinese Herb Therapy for Primary OsteoporosisUsing the Consort Statment and improved Jadad Scale[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2015,23(01):22-25.
点击复制

基于Consort声明和改良Jadad量表评价中药治疗原发性骨质疏松症
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第23卷
期数:
2015年01期
页码:
22-25
栏目:
文献研究
出版日期:
2015-01-15

文章信息/Info

Title:
Accessing on Chinese Herb Therapy for Primary OsteoporosisUsing the Consort Statment and improved Jadad Scale
文章编号:
1005-0205(2015)01-0022-04
作者:
马少华1; 李同林1; 马勇2△;
1.南京中医药大学骨伤研究所(南京,210029)
2.江苏省中医院骨伤科
△.通讯作者 E-mail:zhongyi-my@263.net
Author(s):
Ma Shao-hua1; Li Tong-lin1; Ma Yong2;
1.Insitute of Orthopaedics and Traumatology, Nanjing university of Traditional Chinese Medicine, Nanjing 210029, China
2. Departmemt of Orthopaedics and Traumatology, Jiangsu Hospital of TCM,Nanjing 210029, China
关键词:
中药;  原发性骨质疏松;  Consort声明;  Jadad量表
Keywords:
chinese herb;  primary osteoporosis;  consort statement;  jadad scale
分类号:
R681
文献标志码:
A
摘要:
目的:探讨采用Consort声明及改良Jadad量表评价中药治疗原发性骨质疏松症临床随机对照试验(RCT)的报告质量。方法:计算机检索中国知网(CNKI)、中国生物医学文献数据库(CBM)、维普(VIP)、万方四个数据库,手工检索所有中医药类核心期刊及纳入文献的参考文献,对纳入的44篇文献采用Consort声明及改良Jadad量表进行质量评价。结果:根据Consort全部22条评价条目,纳入分析的44篇文献中,32篇文献描述了患者基线数据及临床特征,8篇阐述了随机分配的方法,尚无文献提及样本量的计算及分配隐藏,2篇采用盲法。根据改良Jadad量表评价44篇文献0～3分的有37篇,4～7分的7篇。结论:目前国内关于中药治疗原发性骨质疏松症的临床随机对照试验文献质量普遍较低,呼吁今后采用国际公认Consort声明和改良Jadad量表对中药治疗原发性骨质疏松症RCT进行规范化实施及报道。
Abstract:
Objective: To access the reporting quality of randomized controlled trials(RCTs)on Chinese herb therapy for Primary osteoporosis by Consort statement and improved Jadad scale. MethodS: Four databases including the CNKI, CBM, VIP and WanFang(2009～2014)were searched systematically by using internet. Handsearch for journals about all core traditional medicine peridoical and future reference were conducted. Accessing the reporting quality of 44 RCTs by using the Consort Statment and improved Jadad scale. Results: In regard to the items in the Consort statments, 32RCTs described baseline demographic and clinical characteristics, 8RCTs described the method of generating the random sequence, 2 RCTs used blinding and no RCT reported the method to calculate the sample size. In regard of the improved Jadad scale, 37 reports scored 0～3 points and 7 reports scored 4-7 points. Conclusion: Currently, the quality of domestic RCTs on Chinese herb therapy for Primary osteoporosis are still low and the Consort Statment and improved Jadad scale should be used to standardize the reporting RCTs of Chinese herb therapy for Primary osteoporosis.

参考文献/References:

[1] 胡军,张华.骨质疏松症的流行病学趋势与防治进展[J],临床荟萃,2011, 26(8):729-731.
[2] 刘健美,薛良,田殿兴. 骨康片治疗原发性骨质疏松症的临床研究[J].世界中西医结合杂志, 2012, 7(4): 323-325.
[3] 胡晓东. 中医治疗老年骨质疏松患者164例临床探讨[J].中医临床研究, 2011, 3(3): 94-95.
[4] 闵文,黄桂成,马勇,等. 补肾通络对原发性骨质疏松症中医证候影响的临床研究[J].南京中医药大学学报, 2010, 26(5): 344-346.
[5] 林一峰,邵敏,刘庆思.中药骨康治疗绝经后骨质疏松症患者2年临床研究[J].中国骨质疏松杂志, 2009, 15(4): 288-291.
[6] MOHER D, HOPEWELL S, KENNET F S, et al. Consort 2010 说明与详述:报告平行对照随机临床试验指南的更新[J].中西医结合学报,2010,8(8):701-739.
[7] JADAD A R, MOORE R A, CARROLL D, et al. Accseeing the quality of reports of randomized clinical trials:is blinding necessary[J]. Control clin Trials,1996, 17(1):1-12.
[8] SUHULZ K F, CHALMERS I, HAYES R J, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials[J]. JAMA, 1995, 273(5):408-412.
[9] ALTMAN D G, SCHULZ K F, MOHER D, et al. The revised Consort statement for reporting randomized trials: explanation and elaboration[J]. Ann Intern Med. 2001, 134(8):663-694.

备注/Memo

备注/Memo:
收稿日期:2014-07-10
基金项目:康缘中医药科技创新与奖励基金项目(HZ1004KY)
更新日期/Last Update: 2015-02-20